Announcement on Jade Silkworm Granules Entering Phase 2 Clinical Trial Study
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Jade Silkworm Granules Entering Phase 2 Clinical Trial Study
Filed with SSE ·
6ix hasn’t read this filing yet.
Humanwell Healthcare (Group) Co.,Ltd. on 6ix
Earlier from Humanwell Healthcare (Group) Co.,Ltd
- Announcement on Obtaining Drug Registration Certificate for Icosapent Ethyl Soft Capsules
- Indicative Announcement on Equity Change of Controlling Shareholder and Its Persons Acting in Concert Reaching 1%
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Obtaining Drug Registration Certificate for Remimazolam Besylate for Injection with Increased Indications
- Announcement on Implementation of Dividend Distribution for 2024
Later from Humanwell Healthcare (Group) Co.,Ltd
- Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
- Announcement on Obtaining Drug Registration Certificate for Levonorgestrel Tablets
- Announcement on Temporary Approval Number Granted by the US FDA for Oxcitabine Sustained-release Tablets
- Announcement on Progress in Signing of "Financial Services Agreement" and Related Party Transactions
- Announcement on Resolutions of the 3rd Meeting of the 11th Board of Directors
Follow Humanwell Healthcare (Group) Co.,Ltd into a list and get an email when it puts out news.
Follow Humanwell Healthcare (Group) Co.,Ltd